Chemoinformaics analysis of NORTRICYCLOEKASANTALIC-ACID
| Molecular Weight | 395.503 | nRot | 7 |
| Heavy Atom Molecular Weight | 366.271 | nRig | 24 |
| Exact Molecular Weight | 395.221 | nRing | 6 |
| Solubility: LogS | -4.639 | nHRing | 1 |
| Solubility: LogP | 4.112 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 4 | APOL | 63.453 |
| nHD | 2 | BPOL | 33.109 |
| QED | 0.694 |
| Synth | 3.619 |
| Natural Product Likeliness | -1.003 |
| NR-PPAR-gamma | 0.864 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.014 |
| HIA | 0.004 |
| CACO-2 | -4.929 |
| MDCK | 0.000027 |
| BBB | 0.053 |
| PPB | 0.924548 |
| VDSS | 0.326 |
| FU | 0.0273984 |
| CYP1A2-inh | 0.119 |
| CYP1A2-sub | 0.078 |
| CYP2c19-inh | 0.495 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.697 |
| CYP2c9-sub | 0.971 |
| CYP2d6-inh | 0.271 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.162 |
| CYP3a4-sub | 0.029 |
| CL | 2.941 |
| T12 | 0.072 |
| hERG | 0.025 |
| Ames | 0.013 |
| ROA | 0.133 |
| SkinSen | 0.041 |
| Carcinogencity | 0.395 |
| EI | 0.015 |
| Respiratory | 0.607 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.634596 |